Aug 28, 2019

Promising efficacy signals for Starpharma’s DEP® trials

Promising efficacy signals for Starpharma’s DEP® trials

Biotech trade publication noted Starpharma announced promising efficacy signals in its ongoing clinical trials for both DEP® cabazitaxel and DEP® docetaxel.

To read the full article, click here.

 This contains certain forward-looking statements.